Aptuit appoints Operations and General Manager in Verona, Italy

Manuela Leone will oversee Aptuit’s drug discovery and development operations

Contract research organisation Aptuit has appointed Manuela Leone as Executive Vice President, Operations and General Manager of the Aptuit Centre for Drug Discovery & Development in Verona, Italy. In this role, Leone will oversee Aptuit’s drug discovery and development operations.

Leone has been in global R&D executive management, general management and presidential roles for the past 20 years. Most recently, she was President of Contract Research Services at Harlan Laboratories.

Prior to this, she was with ICON Clinical Research as Senior Vice President of Clinical Operations and Strategic Alliances.

Before joining ICON, Leone was a Global Head of Clinical Development and Development Operations with Galderma Pharmaceuticals following leadership positions at Fidia and Pharmacia, Upjohn in Milan.

You may also like

Media

Evotec to acquire Aptuit, expanding leadership in external innovation

Evotec and Aptuit have entered into a definitive agreement, Evotec will acquire Aptuit for US$ 300 million
Research & Development

Aptuit and Chiesi initiate discovery project to identify compounds to treat idiopathic pulmonary fibrosis

Both parties will contribute scientifically, with Aptuit providing integrated early discovery capabilities, including medicinal chemistry and pharmacology, as well as drug metabolism and pharmacokinetics, to identify promising compounds for further preclinical development
Research & Development

Aptuit and Dimension Therapeutics partner to advance AAV gene therapies

Activities have commenced for three gene therapy programmes in rare disease indications
Research & Development

Aptuit acquires Kuecept

Expanding capabilities in formulation development to include specialist pre-formulation, formulation prototyping and formulation development services
Research & Development

Aptuit announces acquisition of Exquiron Biotech

Company expands capabilities in discovery to include high throughput screening and other early discovery services
Research & Development

Aptuit to invest US$16m in capacity and capabilities

Will also hire 90 additional scientists during 2016
Manufacturing

Aptuit invests in expanding manufacturing scale and adds new formulation capabilities

Offers manufacturing to Phase III and commercial scale
Subscribe now